Summary
In general, rises in systolic blood pressure to over 200mm Hg during exercise with a workload of 100W are regarded as pathological. Excessive exercise blood pressure values are to be expected in principle in all hypertensives. However, there are so far no generally accepted criteria for diagnosis of isolated systolic exercise hypertension (with normal values of resting blood pressure). The incidence of isolated systolic exercise hypertension is estimated to be about 10% of a selected population. In patients with excessive rises in blood pressure during exercise who want to engage actively in sport, general measures (reduction of obesity, restriction of alcohol and salt intake) and endurance training should be recommended initially. For endurance training, sporting activities that involve dynamic exercise are to be recommended (walking, running, mountain hiking, cycling, swimming, cross-country skiing). Activities involving isometric exercise (rowing, diving, tennis) and sport of a competitive nature are not suitable.
In moderately severe and severe hypertension (diastolic blood pressure values in excess of 105mm Hg), sporting activities and endurance training are contraindicated. If the exercise blood pressure values cannot be lowered below 220mm Hg with the general measures mentioned, pharmacotherapy is to be considered. The drugs of choice for suppressing excessive rises in blood pressure during exercise are β-blockers. In this group, β1-blockers are to be preferred to non-selective β-blockers because of the metabolic neutrality of the former. β-Blockers without intrinsic sympathomimetic activity (ISA) lower the blood pressure-pulse rate product more effectively than β-blockers with ISA. Alternatively, calcium antagonists of the verapamil type and ACE inhibitors can be employed. Diuretics, α1-blockers and calcium antagonists of the nifedipine type are less suitable for monotherapy, since they do not lower the systolic blood pressure-pulse rate product sufficiently during exercise. However, the latter substances can be used in combination with the former drugs.
Similar content being viewed by others
References
Fagard R. Habitual physical activity, training and blood pressure in normo- and hypertension. International Journal of Sports Medicine 6: 57–62, 1985
Fagard R, Bulpitt C, Lijven P, Amery A. Response of the systemic and pulmonary circulation to converting enzyme inhibitors. Circulation 65: 33–37, 1982
Franz IW. Zur Wirkung des α1-Rezeptorenblockers Prazosin und des β1-Rezeptorenblockers Acebutolol bei Hochdruckkranken. Zeitschrift für Kardiologie 73: 21–28, 1981
Franz IW. Assessment of blood pressure response during ergometric work in normotensive and hypertensive patients. Acta Medica Scandinavica 670 (Suppl.): 35–48, 1983
Franz IW, Lohmann FW. Der Einfluss einer chronischen, sogenannten kardioselektiven und nicht kardioselektiven Betarezeptorenblockade auf den Blutdruck, die O2-Aufnahme und den Kohlenhydratstoffwechsel. Zeitschrift für Kardiologie 68: 503–508, 1979
Franz IW, Lohmann FW, Koch G, Quabbe HJ. Aspects of hormonal regulation of lipolysis during exercise. International Journal of Sports Medicine 4: 14–20, 1983
Gould BA, Hornung RS, Mann S, Subramanian VB, Raftery EB. Nifedipine or verapamil as sole treatment of hypertension. Hypertension 5 (Suppl. II): 91–96, 1983
Houben H, Thien T, deBoo T, Lemmens W, Binkhorst R, et al. Hemodynamic effects of isometric exercise in hypertension treated with selective and nonselective beta-blockade. Clinical Pharmacology and Therapeutics 34: 164–169, 1983
Jones RJ, Gould BA, Hornung RS, Mann S, Raftery EB. Intraarterial ambulatory blood pressure monitoring in the assessment of antihypertensive drugs. In Weber et al. (Eds) Ambulatory blood pressure monitoring, pp. 233–241, Steinkopff, Darmstadt, 1984
Kindermann W, Scheerer W, Salas-Fraire O, Biro G, Wölfing A. Verhalten der körperlichen Leistungsfähigkeit und des Metabolismus unter akuter beta1-und beta1/2-Blockade. Zeitschrift für Kardiologie 73: 380–387, 1984
Klaus D. Differentialtherapie der Belastungshypertonie. Herz 12: 146–155, 1987
Kleiner HD, Denby L, Clark L, Pregibon D, Jason M, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 68: 470–476, 1983
Koch G. Hemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoceptor blockade by labetalol. British Heart Journal 41: 192–197, 1979
Kostis JB, Ruddy M, Cosgrove N, Schneider SH, Krieger S, et al. Different exercise responses of hypertensives to beta-blockers and angiotensin converting enzyme inhibitors. European Heart Journal 5 (Suppl. I): 140–146, 1984
Kumar EB, Nelson GI, Silke B. Circulatory dose-response effects of hydrochlorothiazide at rest and during dynamic exercise. Journal of the Royal College of Physicians of London 16: 232–237, 1982
Lorimer AR, Barbour MB, Lawrie TDV. An evaluation of the effect on resting and exercise blood pressure of some first line treatments in hypertension. Annals of Clinical Research 15: 30–34, 1983
Lund-Johansen P. Hemodynamic response: decrease in cardiac output vs reduction in vascular resistance. Hypertension 5 (Suppl. III): 49–57, 1983a
Lund-Johansen P. Short- and long-term hemodynamic effect of labetalol in essential hypertension. American Journal of Medicine 75: 24–31, 1983b
Manhem P, Hökefelt B. Prolonged clonidine treatment: cate-cholamines, renin activity, aldosterone following exercise in hypertensives. Acta Medica Scandinavica 209: 253–260, 1987
McLeod AR, Brown JE., Kitchell BB, Sedor FA, Kuhn BC, et al. Hemodynamic and metabolic responses to exercise after alpha-, beta1- and nonselective beta-adrenoceptor blockade. American Journal of Medicine 76(2A): 96–102, 1984
Nannan ME, Vanbutsele RJ, Melin JA, Lavenne F, Detry JMR. Hemodynamic effects of nitrendipine at rest and during exercise in essential hypertension. European Heart Journal 5 (Suppl. 1): 139–146, 1984
O’Hare JA, Murnaghan DJ. Failure of antihypertensive drugs to control blood pressure rise with isometric exercise in hypertension. Postgraduate Medical Journal 57: 552–555, 1981
Sokolow M, Werdegor D, Kain HK, Himman AT. Relationship between level of blood pressure measured casually by portable recorders and severity of complications in essential hypertension. Circulation 34: 279–290, 1966
Stroker IB, Greenharah N, Linden RJ, Barbour MP, Lorimer AR, et al. Effects of exercise in hypertensives controlled with metoprolol or methyldopa. Clinical Science 57: 391–394, 1979
Vandenburg MI, Holly JM, Godwin FJ, Sharman VL, Marsh FP. The effect of captopril and propranolol in the responses to posture and isometric exercise in patients with essential hypertension. European Journal of Clinical Pharmacology 25: 721–728, 1983
Wilson NV, Meyer BM. Early prediction of hypertension using exercise blood pressure. Preventive Medicine 10: 62–68, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klaus, D. Management of Hypertension in Actively Exercising Patients. Drugs 37, 212–218 (1989). https://doi.org/10.2165/00003495-198937020-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198937020-00008